Abstract:Abstract Background A growing body of evidence suggests that epithelial cell-derived microRNAs are involved in the pathogenesis of inflammatory bowel disease (IBD). This immunological impairment leads to altered colonic epithelial permeability and the release of inflammatory cytokines, such as IL-33. In this prospective cohort study, we studied the expression of epithelial cell-derived microRNAs (miRNA) in Crohn’s disease (CD) patients compared to healthy controls. We also investigated their potential role in regulating inflammation in experimental IBD animal models. Methods We prospectively collected terminal ileum tissue samples via ileocolonoscopy from non-IBD healthy control (n=26), CD patients in remission (n=34) and active CD patients (n=42). CD remission was defined as clinical remission with a Crohn’s disease activity index score of less than 150 and the achievement of endoscopic mucosal healing. Both inflamed and non-inflamed lesions were sampled in the active CD patients. miRNA levels were measured by small-RNA sequencing and also validated via qRT-PCR. Diagnostic abilities of specific miRNAs found were evaluated by receiver operating characteristic (ROC) curve analysis. A signature of miRNAs was selected from RNA sequencing and qRT-PCR and single-strand mimics of these miRNAs were delivered in the 2.5% dextran sodium sulfate colitis model to determine the effect. Histologic grading and immunohistochemistry evaluation and flow cytometry analyses were performed. Results From the prospective study cohort of CD and non-IBD healthy control (mean follow-up period of 13.06 months), we found a distinct array of miRNAs between groups. Small-RNA sequencing of CD patients in remission and active state (both in inflamed and non-inflamed tissue) revealed distinct microRNA profiles. Through qRT-PCR validation, we found that the expression levels of miR-141-3p, miR-338-3p, miR-378a-3p, and miR-200b-3p were significantly decreased, while miR-125b-5p, miR-29b-3p and miR-155-5p were significantly increased in the inflamed tissue of active CD patients. ROC curve analysis of these miRNAs suggested that they have varying diagnostic activities related to both clinical disease activity and endoscopic inflammation status. In an IBD animal model, the delivery of miR-338-3p and miR-378-3p demonstrated an anti-inflammatory effect, as evidenced both histologically and in immunohistochemistry data, as well as in flow cytometry analyses. Consistent results were observed when these two miRNAs were combined. Conclusion We report miR-338-3p and miR-378a-3p as distinct features in mucosa of CD patients and these data support the promising future of use of these miRNAs as potential therapeutic targets for novel IBD therapies.

Lncrnacnn3-206 Activates Intestinal Epithelial Cell Apoptosis and Invasion by Sponging Mir-212, an Implication for Crohn's Disease

Profiling the Lncrna-Mirna-mrna Cerna Network to Reveal Potential Crosstalk Between Inflammatory Bowel Disease and Colorectal Cancer

LINC01272 Activates Epithelial-Mesenchymal Transition Through Mir-153-5p in Crohn’s Disease

LINC01272 Activates Epithelial-Mesenchymal Transition Through Mir-153-5p in Crohn's Disease.

Expression Alteration of Long Non-Coding RNAs and Their Target Genes in the Intestinal Mucosa of Patients with Crohn’s Disease

The role of long non-coding RNA in Crohn's disease

Sa1730 Gastric Cancer Related Lncrna-Mtm Involved in Cell Migration and Invasion by Interacting with MT1F

Plasma Long Noncoding RNA Expression Profile Identified by Microarray in Patients with Crohn's Disease.

MicroRNA-143 Targets ATG2B to Inhibit Autophagy and Increase Inflammatory Responses in Crohn's Disease

CCAT1 Lncrna Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier Via Downregulating Mir-185-3p

Lnc-ITSN1-2, Derived from RNA Sequencing, Correlates with Increased Disease Risk, Activity and Promotes CD4+T Cell Activation, Proliferation and Th1/Th17 Cell Differentiation by Serving As a Cerna for IL-23R Via Sponging Mir-125A in Inflammatory Bowel Disease

LncRNA-miRNA-mRNA Network Analysis Reveals the Potential Biomarkers in Crohn’s Disease Rats Treated with Herb-Partitioned Moxibustion

Circular RNA Expression Alterations in Colon Tissues of Crohn's Disease Patients

Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease

Targeting NCAPD2 As a Therapeutic Strategy for Crohn’s Disease: Implications for Autophagy and Inflammation

Targeting NCAPD2 as a Therapeutic Strategy for Crohn's Disease: Implications for Autophagy and Inflammation

P002 Regulation of miR-338-3p and miR-378a-3p in the intestinal mucosa of Crohn’s disease: Potential targets for modulating inflammation

IDDF2018-ABS-0193 Cytokine IL9 mediates the pathogenesis of crohn’s disease through the MIR21-CLDN8 pathway

LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer

Investigating regulatory patterns of NLRP3 Inflammasome features and association with immune microenvironment in Crohn’s disease

CircRNA_103765 Acts As a Proinflammatory Factor Via Sponging Mir-30 Family in Crohn’s Disease